Andrea Douglas’ swim club was so inspired by her journey battling breast cancer that they created a grassroots event called OlymPINK Masters Sprint. Their inaugural event at the Brewer Pool in 2018 blew their goal out of the water with 120 swimmers, including six Olympians, and $19K raised for The Ottawa Hospital’s Rose Ages Breast Health Centre. OlymPINK raised $44K in year two, and last year an incredible $70K, despite the actual swim being cancelled due to COVID-19.
“Thankfully, The Ottawa Hospital is prepared for each and every one of us receiving a cancer diagnosis.”
– Andrea Douglas
Q: What is OlymPINK and what inspired you to create this fundraiser?
A: When I was diagnosed with breast cancer in 2014, my whole world was turned upside down. No one is ever prepared for those words “you have cancer.” Thankfully, The Ottawa Hospital is prepared for each and every one of us receiving a cancer diagnosis. From the very first meeting with my breast oncology surgeon, I knew I was in good hands. And from that day forward, through surgery, chemotherapy and radiation, I received incredible care. For my care and for my health today, I remain grateful and felt it was important to give back to the hospital that had saved my life.
Together with the support of my Masters’ swim coach and many wonderful teammates, we came up with the idea of a fundraiser to support the hospital’s Rose Ages Breast Health Centre. One in eight women in Canada will develop breast cancer—we all know someone — neighbours, sisters, friends, mothers, or daughters who have been and will be impacted, and we need to make sure the most up-to-date technology is at hand when they need it most.
A: You can’t imagine the emotional turmoil you face when you learn about a breast cancer diagnosis or any other life-threatening diagnosis. For those facing breast cancer, it’s important to know that there is the Rose Ages Breast Health Centre that will embrace you with the care you need. And it’s not just about cancer, it’s about breast health. It’s about the best imaging and cutting-edge technology, all under one roof, to guide women through everything from screening to diagnostics to treatment plans.
“We need to work together to be the change, to make that difference, and to save lives.”
– Andrea Douglas
Q: What would you tell someone who might be considering a donation to The Ottawa Hospital?
A: I feel a sense of responsibility that comes with being one of the “lucky” ones. And that’s why I fundraise for The Ottawa Hospital. Because every piece of technology and every bit of research that could mean one less woman faces this disease or has this disease stopped in its tracks sooner, is worth every penny. We need to work together to be the change, to make that difference and to save lives.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Donors
Robert (Bob) Hardy has been in a fight for his life for more than 20 years. From a bone marrow transplant for leukemia, to a blood clot in his intestine and his neck, it seems nothing can slow him down. In fact, thanks to lifesaving care at The Ottawa Hospital, he’s stronger than ever and unwavering in his desire to compete in some of the most renowned marathons around the world — with his walker. Beating his personal best time, year after year, you wouldn’t suspect that this ‘Walker-Runner’ initially had only a 40% chance of survival.
A startling diagnosis
There was a time many years ago when Bob believed he only had six months to live. Feeling slightly fatigued, but healthy overall, he went for a routine physical. When his examination results returned, Bob received startling news. At only 46 years old, and long before experiencing any side effects of the disease, he was diagnosed with leukemia. Bob and his wife, Vittorina, were stunned. All they could think about was how they would tell their two young girls, Shannon and Leah, who at the time were only 13 and nine. “It was a really big shock for all of us. The thought of having to tell our children wasn’t easy, but it wasn’t something I was willing to hide from them either,” said Bob.
But if you’re looking for a woe-is-me attitude, you won’t get it from Bob. Even a diagnosis of this magnitude couldn’t bring him down. “When I told my youngest daughter, Leah, about my diagnosis,” said Bob, “she told me ‘you’re too strong to die, dad.’” That was the encouragement Bob needed to hear. It was her words that motivated him to fight back and beat the disease.
A fight for his life
Up until Bob’s leukemia diagnosis he was studying jiu-jitsu – and fit as ever. But while he waited for a match donor for a bone marrow transplant, the medication, interferon, that doctors prescribed to maintain his health was making him weak. Bob was struggling to continue with his training. “I wanted to get my black belt before undergoing my bone marrow transplant,” expressed Bob. He felt a black belt would give him the confidence he needed to begin the long road to healing and recovery. Knowing just how much this milestone would mean to Bob, his doctors allowed him to temporarily discontinue taking interferon for two months prior to Bob’s black belt test, so that he could continue training for the big day. And when that day came, he got his black belt – with honours. It was only then that he felt ready for his bone marrow transplant and the ups and downs that would follow.
A perfect match
After a year of taking interferon, a six-antigen match donor for the bone marrow transplant was found. At the time, performing a bone marrow transplant using an unrelated donor was still relatively new. But researchers discovered that patients can have a match donor outside of their family. “It isn’t common for two people to have the same set of six antigens if they aren’t blood related. I was lucky. They found a perfect match,” explained Bob. More recently, however, advances in research have allowed our experts to perform a transplant using an incompatible donor, significantly reducing the time patients must wait for a match donor. “What this means is that, where once many did not have a donor, now almost everyone has one,” explained Dr. Huebsch. “This research is truly groundbreaking.”
With a donor ready to help, the pre-transplant treatment of high doses of chemotherapy and radiation to suppress Bob’s immune system began. Four weeks later, his immune system was primed to receive the bone marrow transplant. He underwent this procedure at The Ottawa Hospital, and remained in our care for three weeks to ensure the transplanted healthy cells were multiplying – and they were.
Bone marrow is the soft, fatty tissue inside your bones, which produces blood cells. A transplant, inserted into the blood stream through a catheter, replaces the unhealthy blood forming cells (stem cells) with healthy ones.
Although doctors wanted Bob to remain in hospital for a few weeks post treatment, he was able to go home for the majority of his recovery. In fact, Bob benefited from our innovative outpatient bone marrow transplant program that has allowed thousands of patients to be treated and recover more conveniently from home. This program was one of the first in Canada and, since its inception, our patients have been surrounded by loved ones throughout recovery.
Thrombosis expertise in Ottawa
Over the course of the next two years, Bob was in and out of the hospital. “The first two years were the hardest. I had a lot of side effects from my treatment,” said Bob. One of the most severe side effects Bob experienced was blood clotting. The first to appear was in his stomach and a second in his neck. Cancer patients are often at greater risk of blood clotting as chemotherapy is hard on the veins. Approximately one in every twenty cancer patients will experience blood clotting – often a life-threatening complication. But Bob was in good hands. He benefited from the development of a tool to help diagnose blood clots quickly, known as the Wells Rule, after Dr. Phil Wells, an expert at The Ottawa Hospital. This tool is now used in emergency rooms and taught in medical schools around the world.
“We have one of the best thrombosis departments in Canada, attracting experts in the field from across the globe.” – Dr. Marc Carrier
Researchers have since implemented a comprehensive program for managing blood-thinning medications for patients at higher risk of developing blood clots, including cancer patients like Bob. This program has ensured that patients at our hospital are more likely to have optimal blood thickness, and less likely to develop blood clots.
More recently, our experts have developed a system to identify the likelihood that a cancer patient will develop blood clots. Although this was not yet available at the time of Bob’s diagnosis, this innovative tool can classify newly diagnosed cancer patients as being at greater risk and they can receive personalized care based on their unique circumstance to prevent blood clotting. “We have one of the best thrombosis departments in Canada, attracting experts in the field from across the globe,” said Dr. Carrier, Chief, Division of Hematology. “Our highly specialized and dedicated researchers are developing groundbreaking procedures that demonstrate our commitment to continuously moving research and treatments forward, so that we can continue to provide exceptional care to each patient that walks through our doors,” said Dr. Carrier.
World-class care in Hematology
Throughout Bob’s treatment, he was cared for through The Ottawa Hospital Hematology and Thrombosis Program, one of the best and largest in Canada. Unlike many other hospitals, where patients must travel to different hospital departments and satellite locations to receive treatment, our unique program provides centralized care for patients with diseases of the lymph glands, blood, and bone marrow for patients across eastern Ontario and beyond.
“We are among the best. Ottawa is at the centre of all sorts of blood transfusion medicine and we’re one of the leading centers in the world for doing, and researching, transplantation for life threatening diseases.” – Dr. Lothar Huebsch
The program, which has attracted leading researchers from around the world, is renowned for the development and advancement of world-first procedures that are changing lives. “We are among the best,” explained Dr. Huebsch, Clinical Hematologist and former head of hematologic oncology. “Ottawa is at the centre of all sorts of blood transfusion medicine and we’re one of the first in the world to successfully perform transplantations for life threatening diseases.” Our Hematology and Thrombosis Program has led the way for decades, researching transplant techniques with other illnesses such as multiple sclerosis, autoimmune diseases, and lymphoma. “This is the kind of research we’ve done for 25 years, and we are one of the leading centers in the world for doing these transplants in the outpatient setting, rather than in a high intensity ward as an impatient,” said Dr. Huebsch.
Road to recovery inspires ‘walker-running’
With so much time spent in and out of hospital throughout his treatment, Bob needed something to do to keep himself busy while he recovered. So, he got creative. “A few of us used to take our IV polls and race them down the hallways. The nurses couldn’t believe how fast we were moving!” What Bob didn’t realize at the time was racing IV polls would later spark aspirations to participate in some of the most renowned marathons.
Following treatment for the blood clot in his neck, Bob lost his sense of balance. Although he can walk short distances without an aid, he’s unable to run or walk long distance. That’s when Vittorina suggested he get a walker. “At first, I was hesitant about using a walker, but then I realized how fast I could move!” said Bob. And so began his passion for ‘walker-running’.
Bob started his walker-running career participating in the Wobbly Walker-Walk-a-thon, but soon shifted into high gear signing up as a marathoner in Run for a Reason at Tamarack Ottawa Race Weekend. His marathons not only accomplished a personal goal, but also raised funds in support of The Ottawa Hospital.
A new appreciation for life
Bob’s road to recovery hasn’t been an easy one, but there hasn’t been a day he’s felt sorry for himself. Over the years he started to get stronger and complications were fewer and far between. “I am so thankful for the treatment I received. The nurses and my doctors were outstanding – absolutely incredible,” said Bob. “I’m here today, pursuing my passion for walker-runner marathons, because of them. They saved my life.”
Of course, there are still some days that Bob feels more run down than others. On those days he tries to take a walk to reminisce on how far he’s come in his recovery. “I know what it takes to get over things and to get through things. Not only did I have the very best care at The Ottawa Hospital, I had something to live for. I was able to watch my girls grow up. And now, here I am at age 69, almost 70, I’ve overcome countless obstacles and have jumped over hurdles, and I’m really quite happy with my life. I’m really very happy.”
“I am so thankful for the treatment I received. The nurses and my doctors were outstanding – absolutely incredible.” – Bob Hardy
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Creating Tomorrow, Creating Tomorrow, Run for a Reason, World-Leading Research
Update: September 2024
We were deeply saddened to learn that on Friday, September 13, 2024, Sindy Hooper passed away from pancreatic cancer. She defied the odds, surviving for 11 years following her diagnosis.
Sindy worked tirelessly to raise money for cancer research at our hospital. Shortly after her learning she had cancer, she recruited 100 people to run in Tamarack Ottawa Race Weekend, and they raised more than $100,000. In the years since, the team, which is now called Make Every Moment Count (MEMC), has grown and has raised more than half-a-million dollars for cancer research.
Last November, these efforts were celebrated publicly when Sindy was honoured with the Association of Fundraising Professionals 2023 Inspiration Award in recognition of her unwavering courage and dedication to giving back.
We extend our deepest sympathies to her husband Jon, her sons, Chris and Will, the entire MEMC crew, and her extensive group of friends and family.
Devastated and shocked – that’s how Sindy Hooper and her family reacted to the diagnosis of pancreatic cancer in 2013. Especially considering pancreatic cancer survivor rates are so low. The diagnosis came at a time when Sindy would have described herself as being in the best shape of her life. But suddenly, she was facing the fight of her life, and she looked to the specialized cancer treatment and research at The Ottawa Hospital to help her fight back.
In the months leading up to Sindy’s diagnosis, she had been feeling great. She had completed her first Ironman in August 2012, and that fall she was training to complete another one. Then, in December, she started experiencing discomfort in her upper abdomen and pain in her upper back. However, towards the end of the month her skin started to get very itchy, she became a lot more tired, and she started to lose a little bit of weight. The day before her diagnosis, she woke up and her eyes were yellow. She was jaundiced.
Sindy’s husband, Dr. Jon Hooper, an ICU physician at The Ottawa Hospital, initially thought it could be gallstones. The couple headed to hospital unprepared for what they were about to learn. Later that day, an ultrasound would reveal it was pancreatic cancer. “We couldn’t believe the news. I was relatively young. I had just turned 50. I was in the best shape of my life. I had no family history of cancer whatsoever,” says Sindy. Even more alarming were the survival rate statistics.
The MEMC Movement
When Sindy Hooper was diagnosed with pancreatic cancer in January 2013, a movement was born.
The pancreas is part of the endocrine system, a group of glands and cells that make and release hormones into the blood, controlling growth, reproduction, sleep, hunger, and metabolism. The cells in the pancreas normally make and release digestive juices to help break down food.
Pancreatic cancer starts in the cells of the pancreas. A malignant tumour of the pancreas is a group of cancer cells that can grow into and destroy nearby tissue. It can also spread to other parts of the body. There has been little progress in the fight against pancreatic cancer in the last 40 years.
The five-year survival rate is only eight percent. The average survival is six months and 75 percent of the people diagnosed with this form of cancer die within the first year.
“We see what people are going through and how we need to do better than we’re doing so far. It gives us a focus and purpose because we know here’s an urgent need for new and better therapies.”
Pancreatic cancers are resistant to most kinds of therapy. The cells have a biology that scientists don’t completely understand, which makes them hard to detect early and hard to treat with conventional kinds of therapies that are currently available. Researchers at The Ottawa Hospital are working to offer hope to pancreatic cancer patients and while she didn’t realize it at the time, this would become very important to Sindy and her journey.
Ready for specialized care
With the alarming news of the diagnosis, Sindy prayed to make it to one year. Her team at The Ottawa Hospital developed a three-pronged care plan. “I am very thankful for having such amazing care close to home – really world-class care,” says Sindy.
The treatment would begin with Whipple surgery. “It’s a seven-hour operation – it’s huge. It can only be done in very specialized centres. I was very fortunate to have that done here in Ottawa.”
In fact, The Ottawa Hospital is one of the few hospitals in Canada to offer this type of surgery. It is used to remove tumours in the head of the pancreas or in the opening of the pancreatic duct. A team that specializes in surgery of the pancreas, liver, gallbladder, and bile duct work together to support the patient through the operation.
In Sindy’s case, the complex surgery removed half of her pancreas, half of her stomach, her gall bladder, bile duct, duodenum, and the tumour. She was in hospital for ten days and then recovered at home for the next five weeks. “Just as I started feeling better in mid-February, I started chemotherapy. I went through 18 rounds of chemo that took me to September. There was also 28 days of radiation in between,” remembers Sindy.
“Whipple surgery is a seven hour operation – it’s huge. It can only be done in very specialized centres. I was very fortunate to have that done here in Ottawa.”
She was able to withstand the effects of chemo and radiation very well. Her doctors attributed that to the great shape Sindy was in. It helped her power through the treatments. “Through all my treatments, I was still training for Ironman Canada.”
Powering through to Ironman Canada
Feeling good, Sindy and Jon booked a trip to Whistler, B.C. to take on Ironman Canada in August 2013, even though Sindy was still undergoing chemo treatment. She wasn’t expecting to complete the biking or running portion, but Sindy felt she could tackle the 3.86 km swim. In fact, she not only finished the swim, but also the 180 km bike, and the marathon. “We started the marathon, and it was miraculous. I just felt so good that day. I had lots of energy.”
In the end, together, they finished the Ironman at 11:37 p.m. – 23 minutes before the cut off. But it was bigger than just crossing the finish line. Sindy’s incredible strength to power through an Ironman in the middle of chemotherapy treatment attracted significant media attention. She not only increased awareness for pancreatic cancer, but she also raised $50,000 for cancer research. “Completing the Ironman, raising awareness, and all that money was an absolute gift in the midst of everything I was going through,” says Sindy.
Fundraising for all cancer patients
That $50,000 was just the starting point for this crusader. Sindy has dedicated herself to fundraising for cancer research at The Ottawa Hospital since 2014 through Run for a Reason at Tamarack Ottawa Race Weekend. Her running team is the MEMC crew (Making Every Moment Count). She tries to instill her passion for life in other people and not take things for granted. Along the way, she’s raised over $225,400 for cancer research.
Sindy does it not only for herself but also for other patients. “Cancer research is going to one day save my life again, I’m sure of it.”
“Cancer research saves lives. That’s the bottom line. Whether it’s finding new treatments or early detection methods so cancers can be picked up earlier and treated more effectively – cancer research really does save lives.”
For Dr. John Bell, a senior scientist, who’s been investigating this complicated disease for decades at The Ottawa Hospital, it’s patients like Sindy who inspire him and his team of researchers. “I’m really privileged to have a lab at the Cancer Centre. That means every day, I get to see the people we are trying to help, like Sindy, who we want to have a good quality of life and a long life.”
Dr. Bell adds it’s those patients who push him to find answers and that elusive cure. “We see what people are going through and how we need to do better than we’re doing so far. It gives us a focus and purpose because we know there’s an urgent need for new and better therapies.”
One way to find those answers is through clinical trials. And it’s not lost on Dr. Bell that the patients who participate are both courageous and altruistic. “Every patient seems to say the same thing when I speak with them: ‘I don’t know if this is going to work for me, but I hope you learn something from it so that I can help somebody else.’ That’s, really what we get inspired by, that sort of attitude. Sindy has that attitude for sure.”
Finding hope for pancreatic cancer patients
While treatment options for pancreatic cancer are still limited, there is hope. Researchers at The Ottawa Hospital are leading the world in developing viruses that can attack cancer cells without harming normal cells. These viruses have been tested in clinical trials for other types of cancer, and Dr. Bell’s team is currently working in the laboratory to see if they can be customized for pancreatic cancer. Dr. Bell says that, “absolutely,” the findings from those previous trials could be used in future pancreatic cancer patients.
“It really is I think a burgeoning field, and I like to think we were critical in getting this started.”
As Sindy continues to put her faith in what this research will have to offer in the future, she has a simple message for Dr. Bell and his team. “Thank you for the work that you’re doing.”
“Keep working really hard because there’s a lot of people out there, like me, who are relying on research to find new, better treatments and hopefully one day a cure.”
2020 brings a new health concern
Even before the emergence of COVID-19, 2020 offered a new challenge to Sindy. On a flight to Hawaii, last winter she, started experiencing intense gastrointestinal pain. As soon as her flight landed, she went straight to the hospital and learned she had a partial obstruction in her GI tract. While she started to feel better, her surgeons back at The Ottawa Hospital encouraged her to return home as they were the best equipped to handle her complicated case should she develop another obstruction and she need surgery.
Back home, Sindy continued to have severe episodes of pain, developed a fever, and then a blood infection. By mid-April, COVID-19 had arrived in Ottawa and doctors were hesitant to operate, but the pain became so severe they had no choice.
Surgeons discovered a significant number of adhesions in the area of her obstructions and removed them. Sindy admits it was a stressful time being in hospital during a global pandemic. “It was so scary by myself – not having my husband there for me.”
Although, she gives credit to the incredible staff who were at her bedside for six days. “I have to say everybody was going above and beyond to make the patients feel comfortable during this time. I was impressed.”
Making plans for the future
Today, Sindy celebrates as a seven-year pancreatic cancer survivor and takes nothing for granted. After she got past that first year of survival, she prayed for two years of survival. “Every year that has passed is just completely incredible to me, Jon, and my sons.”
Every six months Sindy returns to The Ottawa Hospital for a CT scan. While it’s stressful waiting for the results, so far, each scan has resulted in good news, allowing Sindy and Jon to make plans for the next year.
This year, that plan included welcoming a new member of the family – Lexey, a French Bulldog – filling their home with joy. Sindy’s plans also include more running, swimming, and biking. She’s feeling strong again after her surgery, back to training for a 50 km Ultramarines Run in November and a triathlon next summer. She continues to look to the future.
“I’m just so amazed to be defying these odds and to get to continue living, enjoying and loving life.”
You could say that Sindy is making every moment count.
Listen to Sindy Hooper’s story in her own words during a guest appearance on Pulse: The Ottawa Hospital Foundation Podcast.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories:
George was faithful when it came to his annual health checkups and was fortunate enough to have always been relatively healthy. For that reason, he didn’t think too much of it when his prostate-specific antigen (PSA) numbers started to creep up. But his family doctor referred him to The Ottawa Hospital where he met urologist Dr. Brian Blew who ordered a biopsy. The results were shocking – prostate cancer. It was the beginning of a health journey George never anticipated, finding himself at the centre of a cancer battle under the care of an exceptional team of doctors, nurses, and radiotherapists. Now, more than a year later, George is a proud monthly donor to the hospital, determined to give back through philanthropy and volunteering his time to help other patients.
Shocking news
In April 2019, George and his wife Maria, had just returned from an annual trip to Mexico when he received the news that the biopsy results showed he had prostate cancer. George’s PSA levels had always been on the higher side and the recent increase could very well have been a result of aging, so he was shocked to learn that he had intermediate risk prostate cancer. Dr. Blew offered George two options: have the prostate removed surgically or undergo radiation. George wanted to act quickly and felt radiation was his best course of action. “I wanted to get on this right away, so I immediately started radiation. I had 20 treatments in total. I felt very fortunate because I know some men need to have more.” said George.
“We have a rare gem of a facility here in Ottawa and by giving, I know it will help future patients receive the same level of care I received.” – George Knight
Compassionate care
George was grateful for the quick treatment and for how well he was taken care of. “I had excellent care from all of my doctors. Dr. Blew, Dr. Alain Haddad, and Dr. J.M. Bourque, and all of the nurses and radiotherapists. They were all absolutely amazing. I couldn’t have asked for any better.” While he was understandably worried, his care team quickly put him at ease.
Following his radiation, George is feeling better than ever. He is back to doing his many hobbies and he and Maria are back at the yoga studio where he practices twice a week. “I feel 100% — better than I’ve felt in a long time. I have more energy now and my PSA numbers are back in an acceptable range. I got very lucky. I’m feeling wonderful.”
“George’s donation will allow us to continue to develop the best tools for assessment and treatment.” – Dr. Blew
Accordingly, he thinks the excellent care he received helped him get back to good health quickly, and he wants his story to encourage others to get checked. “We caught it really early so that made a really big difference. Now I nag my male friends that are over 50 years old to go and get checked. They hum and haw but it’s important because sometimes you feel fine, even when you aren’t,” said George.
Dr. Blew is quick to echo the importance of regular screening. “Mr. Knight was very knowledgeable about PSA screening and understood a high PSA is not always due to prostate cancer but requires assessment to determine if treatment is needed instead of monitoring. George’s donation will allow us to continue to develop the best tools for assessment and treatment.”
Turning gratitude into action
The care George received has inspired him to sign up to be a volunteer at the hospital, something he has never done before. “I saw a quote online by Jim Rohn that said, ‘Only by giving are you able to receive more than you already have’ and it really struck a chord with me. This is why I need to give back.” In this same spirit, he has also decided to become a monthly donor. “I trusted the hospital with my health and now I trust it with my support. I want the hospital to have regular support that they can count on. We have a rare gem of a facility here in Ottawa and by giving, I know it will help future patients receive the same level of care I received.”
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Donors, Donors
When Lorne Blahut was diagnosed with HIV in 2000, he thought he was going to die. But experts at The Ottawa Hospital, armed with incredible advances in research, had a different plan. Then in 2017, he again found himself face-to-face with another significant health scare — prostate cancer. But Lorne knew he was in good hands.
“Several years ago, my doctor, Stephen Kravcik, told me, ‘You better start planning for your retirement, because you’re not going to die,’” said Lorne. And he was right. The 67-year-old retired 7 years ago from a career at Canada Mortgage and Housing Corporation.
Lorne’s original fears of dying when first diagnosed with HIV were well founded. It is estimated that more than 32 million people have died from HIV since the early 1980s and the high fatality rates from early-on in the epidemic remained staggering for years. But then research turned the tide.
Excellence in research
“Certainly, the mid-90s was the heyday of HIV research when new drugs were developed. The Ottawa Hospital group did revolutionary research led by Drs. Bill Cameron and Jonathan Angel,” said Dr. Kravcik, who came to The Ottawa Hospital in 1994 specifically to do HIV research and clinical trials for new drugs under the guidance of Dr. Cameron. He said at that time about 125 of their HIV patients passed away every year.
Today, HIV is no longer a death sentence.
“It’s not even a chronic disease. Most people like Lorne take one or two pills a day and their lives are totally normal. The pills are superb. They are well-tolerated and with them patients do really, really well.” – Dr. Stephen Kravcik
When Lorne was first diagnosed 20 years ago, patients diagnosed with HIV/AIDS were living longer thanks to the antiretroviral medications, but it wasn’t common for patients to survive for decades.
“Being diagnosed was a horrific shock,” said Lorne. “And for a while I kept the diagnosis to myself. Being in the gay community, there was the fear that people were going to find out. It was intimidating, it was daunting, but there’s the saying that your worst fears are only realized in your head.”
Lorne’s fears proved unfounded when he realized he was in competent, caring hands.
Helping patients navigate their disease
“A number of people helped navigate the whole disease piece. There was a team around from the beginning,” said Lorne. “Dr. Kravcik explained what was going to happen with the various medications and took the time to listen when I asked for clarification. Kim Lancaster, the social worker on the team, helped with the initial diagnosis, with moving forward, and with issues I was dealing with personally.”
Kim Lancaster, who worked in the infectious diseases clinic for nine years, said the main stay of her job was helping people emotionally manage the impact of receiving an HIV positive diagnosis, and helping them figure out how to conduct themselves in their professional, social, and emotional lives. She said there’s still such a stigma attached to the disease.
“Lorne knew he needed help and was courageous to reach out his hand like that,” said Kim. “In the HIV world, many of the people who don’t live well with the disease are those who are too mired in shame, or fearful of discrimination, to access medical and psychosocial support. They don’t invite people into their medical experience.”
“The care was all encompassing. I’ve not only been looked after physically – bodily – but also, I have had mental support.” – Lorne Blahut
Lorne said the numerous levels of care he received during his treatment in the early years helped him cope with having an illness that is so stigmatized. He also benefited greatly from the research conducted at the hospital, and the antiretroviral drugs developed over the years to keep the disease in remission. Lorne survived. Then he suddenly found himself faced with another life-threatening disease – prostate cancer.
“When you get a diagnosis of cancer, it takes a while to sink in,” said Lorne. But he wanted to be informed about his treatment options.
Minimally-invasive robotic procedure
Lorne read up on the two prostate cancer surgery options before deciding that the robotic surgery, offered at The Ottawa Hospital, was the right one for him. The da Vinci Surgical System is a state-of-the-art robotic system that the surgeon operates remotely, using cameras and tiny surgical instruments. This operation is easier to recover from because it is performed through small incisions rather than the traditional larger incision in the lower abdomen. The Ottawa Hospital was the third hospital in Canada to acquire this minimally invasive surgical system, which was purchased with funding from the community.
“What particularly struck me when comparing the two surgeries was the recovery. The recovery time is longer with the traditional operation because of the significant incision the surgeon has to make, and you wear a catheter for months. There is also a tendency for there to be more nerve damage because it’s not as precise. So, for me it was a no brainer.”
Preparing for surgery
Lorne met with surgeon Dr. Chris Morash, who talked about the possible side effects of prostate cancer surgery. Some individuals experience incontinence and/or sexual dysfunction and some might require hormone therapy after the surgery. Several days later, Lorne met with social worker Liane Murphy and expressed his concerns about all of this.
Liane meets with individuals diagnosed with prostate cancer to help them prepare for their surgery and recovery and to talk through any of their concerns. Her advocacy on Lorne’s behalf led to a positive pre-operation discussion with Dr. Morash who better addressed Lorne’s concerns. In February 2018, Lorne underwent three-hour robotic surgery. He recovered well and is back to enjoying retirement.
World-class care, right here at home
“I moved here in 1992. When I retired seven years ago, someone asked me if I was going to move back to Saskatchewan. First thing that came to mind was, ‘I won’t because I can’t get the healthcare I get at The Ottawa Hospital,’” said Lorne. “Overall, my experience with The Ottawa Hospital has been exemplary. The staff has treated me well and been very supportive. I can’t brag enough about them.”
Lorne is certainly not alone in navigating through the diagnoses and treatment of HIV and prostate cancer. Many men go through similar experiences with these diseases. But when it comes to HIV, Lorne is also trailblazing a new domain in healthcare.
“We don’t have a lot of men his age who have survived HIV,” said Tim Hutchinson, former Director of Social Services at The Ottawa Hospital Cancer Centre who has known Lorne for many years. “He’s a pioneer and role model in what happens next as this population ages, and how it is as a gay man, navigating a healthcare system.”
The Ottawa Hospital is establishing a Research Chair in Gay Men’s Health to create a comprehensive healthcare agenda that will help improve access to, and delivery of gay-relevant healthcare for men of all ages.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Innovation and Technology
Published July 2020
We each have a defining moment in our life — a moment that changes our life forever. For some, that moment is not as clearly defined as it is for others. For Kimberly Mountain, that moment was the discovery of a cancerous brain tumour.
In February, 2011, Kimberly was 28 years old and out with her then-boyfriend, Matt Mountain, when she felt a weird, strong twitch on the right side of her face as they were driving. “Then all I remember is waking up. Our car was pulled over on the side of the highway. Paramedics were there, and I heard Matt say, ‘Kim just had a seizure’,” recalls Kimberly.
Kimberly was rushed by ambulance to the trauma centre at the Civic Campus of The Ottawa Hospital. She would have another seizure, and then an MRI revealed a brain tumour on her right frontal lobe. That moment changed her life.
For two weeks, The Ottawa Hospital became Kimberly’s second home. Her family and Matt never left her side. “Oddly enough, my memories of being in the hospital aren’t of a sad time at all. They are actually some of my favourite memories, filled with friends and family. Everyone I loved was there. And we made friends with the amazing nurses and staff,” says Kimberly.
Awake brain surgery
On March 7, 2011, Kimberly had brain surgery. Her surgeon, Dr. Charles Agbi, would keep her awake for the operation. This is a highly specialized surgical procedure that requires a team approach led by an experienced neurosurgeon and a neuroanesthesiologist. It enables the neurosurgeon to remove tumours that would otherwise be inoperable because they are too close to areas of the brain that control vision, language, and body movement. Regular surgery could result in a significant loss of function. By keeping Kimberly awake, the medical team was able to ask her to move certain body parts and speak during the procedure.
When she thinks back to the operation, she remembers never being worried. “I guess the hospital staff had made me feel safe and confident.”
During surgery, Kimberly could feel the vibrations of the team drilling into her head, but she didn’t mind it. “I kept talking, laughing, and singing Disney songs, like “Hakuna Matata.” I was telling them how I was going to go to Disney World when it was over. Five hours seemed like just one,” says Kimberly.
For Dr. Agbi, this type of interaction is critical to the success of the surgery. “If they’re only answering questions [surgery staff] are asking them, sometimes we might miss something.”
Transformational technology
It is advances in technology like Kimberly experienced that allow neurosurgeons at The Ottawa Hospital to provide transformational care.
In fact, donor support brought a specialized microscope to Ottawa, allowing surgeons to perform fluorescence-guided surgery. The technique requires patients to drink a liquid containing 5-aminolevulinic acid (5-ALA) several hours before surgery. The liquid concentrates in the cancerous tissue and not in normal brain tissue. As a result, malignant gliomas “glow” a fluorescent pink color under a special blue wavelength of light generated by the microscope. This allows surgeons to completely remove the tumour in many more patients, with recent studies showing that this can now be achieved in 70 percent of surgeries compared to the previous 30 percent average. The first surgery of this kind in Canada was performed at The Ottawa Hospital.
“Dr. Nicholas sat down, held my hand, and said the word — cancer. Everything went blurry, and this time I couldn’t stop the tears. I had been strong up until that moment.” – Kimberly Mountain
Oncologist reveals brain tumour is cancerous
When pathology tests on the tumour came back several weeks later, Kimberly met with her oncologist, Dr. Garth Nicholas, and he revealed the news she feared the most. “Dr. Nicholas sat down, held my hand, and said the word — cancer. Everything went blurry, and this time I couldn’t stop the tears. I had been strong up until that moment,” remembers Kimberly.
During her cancer treatment, Kimberly faced 30 rounds of radiation, followed by chemotherapy. Matt, who had proposed during Kim’s long stay in the hospital, took her on trips to amusement parks or convertible drives to help get her through the difficult times. The couple even made a special trip to Disney World. “All I could think of during my brain surgery was how happy and carefree it was there. The world was suddenly much more exciting, and I was aware of every little smell, feeling, and moment—something I think maybe only cancer patients can appreciate.”
This all provided Kimberly with a distraction from the side effects, the tiredness, and the hair loss. Losing her hair was one of the most difficult parts of treatment. “I hated losing my long, beautiful hair.”
Less than a year later, on January 6, 2012, Kimberly received her last chemotherapy treatment. “I asked those pills to eat that cancer.” Her wish would be realized when an MRI could not detect any residual cancer. Kimberly transformed into a cancer survivor.
Through a mother’s eyes
Kimberly has become known for never showing up for an appointment without a small contingent of supporters. She always has her family by her side, including her mother, Cyndy Pearson. Cyndy laughs that Kimberly always has an entourage—even when she learned her tumour was cancerous. “We were all there. When there’s something important, we’re all there. When Dr. Garth Nicholas leaned over, and said, ‘Kim you have cancer,’ we were all crying.”
Cyndy is grateful to The Ottawa Hospital for saving Kimberly, her youngest of three children. She points out March 7, 2011 is a new date circled on the family’s calendar—Kimberley’s re-birthday.
Cyndy is also forever grateful for Dr. Agbi’s care. “If this surgery hadn’t happened, she wouldn’t be having any more birthdays. If the hospital had not been able to save her…” Cyndy’s voice trails off.
“Even if the cancer does come back, I am confident that The Ottawa Hospital will be able to save me again, thanks to its constant innovative research and clinical trials that are making treatment better and saving lives.” — Kimberly Mountain
Cancer survivor ten years later
Today, Kimberly has a tattoo on the back of her neck that reads “Hakuna Matata – March 7, 2011”. She celebrates every milestone — including being cancer free — with family, friends, and of course Matt, who never left her side and who is now her husband. You could say it’s like a Disney ending.
Not everything went back to normal. “My precious hair will never be the same,” says Kimberly. “There’s a big spot where my hair will never grow back. The whole right side of my head is permanently bald.” However, always finding the positive, Kimberly says she can do her hair in ten seconds these days, thanks to a few different wigs, “I may actually own more wigs than shoes.”
All joking aside, Kimberly is grateful for each day. “Even if the cancer does come back, I am confident that The Ottawa Hospital will be able to save me again, thanks to its constant innovative research and clinical trials that are making treatment better and saving lives.”
For now, Kimberly takes it one day at a time, celebrating life’s little moments each day.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Innovation and Technology, Technology
REthinking Clinical Trials (REaCT) is a unique research program aimed at improving the lives of people with cancer through patient-centred, pragmatic clinical trials.
Based at The Ottawa Hospital, the REaCT program engages patients and their loved ones in research every step of the way, from generating ideas to setting priorities to designing studies and sharing results.
Unlike most cancer clinical trials, which are focused on evaluating experimental treatments in a very narrow patient population, REaCT trials compare standard approved treatments in a real-world setting with a broad range of patients. In this way, REaCT trials can efficiently answer some of the most important questions for cancer patients and the health care system.
REaCT is the largest pragmatic cancer clinical trials program in Canada, with more than 2,700 patients participating in 17 clinical trials at 15 centres in Canada.
“Being diagnosed is pretty lifechanging. You feel for other women who are going through this, and so I wanted to give back for the care I was receiving to help other women. I was open to any treatment that was new and innovative. The REaCT trial procedures were straightforward and easy to understand.”
— Connie Chartrand, breast cancer patient, participated in three REaCT clinical trials
Surgeon-scientist Dr. Rebecca Auer is leading a world-first clinical trial that she hopes will protect cancer patients from COVID-19 and other respiratory infections by boosting their immune systems during treatment. The trial was funded in part thanks to donor support to the COVID-19 Emergency Response Fund.
“A cancer diagnosis is scary at the best of times, but the pandemic has made it even worse,” said Dr. Auer, surgical oncologist and Director of Cancer Research at The Ottawa Hospital and associate professor at the University of Ottawa. “Cancer patients have weakened immune systems, which makes them more likely to get severely ill from COVID-19.”
At best, a severe infection could delay a patient’s cancer treatment. At worst, it could kill them.
Patients receiving cancer treatments are the most at risk because the treatments further weaken their immune system. This at-risk population is quite large – over 90,000 people received radiotherapy or chemotherapy treatments in Ontario alone in 2019.
“While there are many specific vaccines for COVID-19 in the works, they won’t be available for at least a year. Cancer patients need protection now.” – Dr. Rebecca Auer
Boosting the immune system during treatment
Dr. Auer and her team at The Ottawa Hospital came up with the idea of testing whether boosting cancer patients’ immune systems during their treatment could help prevent COVID-19 and other respiratory infections. In collaboration with scientists at the Ontario Institute of Cancer Research, they explored an immune-stimulator called IMM-101. Then she worked with Canadian Cancer Trials Group at Queen’s University to design and run the clinical trial at nine cancer centres across Canada.
The researchers will recruit 1,500 patients currently receiving cancer treatment to this clinical trial. Patients will be randomly assigned to receive either regular care, or regular care plus IMM-101. This preparation of harmless heat-killed bacteria had been developed as an anti-cancer therapy because it stimulates the immune system. It has already been safely given to 300 advanced cancer patients in earlier trials.
Training the innate immune system
Dr. Rebecca Auer speaks with a colleague (Photo taken before COVID-19)
This trial takes advantage of a lesser-known aspect of the immune system — innate immunity. This first-response arm of the immune system plays a key role in detecting viruses.
Innate immune cells recognize features that are common to many viruses, allowing them to attack viruses the body has never seen before. This is different from the adaptive immune system, which only recognizes viruses the body has already encountered through prior infection or through a vaccine.
The research team hopes that because the IMM-101 treatment can train the patient’s innate immune system, it will help to fight off the COVID-19 virus, in addition to other viruses that cause respiratory infections.
“There is good data to suggest that the reason some people have no symptoms from COVID-19 while others get very sick is their innate immune system’s ability to respond early and quickly to the virus. This made us consider whether we could use an innate immune booster to prevent COVID-19 infections.” – Dr. Rebecca Auer
Based on data from other immune stimulators, it’s likely that this immune-boost would be temporary. But researchers hope it will last long enough to get a patient through their cancer treatments. Once the treatments have ended, the patient’s immune system would return to its regular strength and be strong enough to fight off viruses on its own.
Protection from more than COVID-19
The advantage of this immune-boosting approach is that it could help cancer patients fight off all sorts of viruses while they are undergoing cancer treatments and are at their most vulnerable.
“The treatment we’re using trains the immune system to do a better job fighting the next viral infection,” said Dr. Auer. “It’s not specific to COVID-19, but actually applies to any viral respiratory illness.”
If successful, IMM-101 could also offer benefits to people with other chronic illnesses or compromised immune systems who are similarly at a heightened risk of serious outcomes from COVID-19. It could also help protect people with cancer from other respiratory infections like the seasonal flu.
Preparing for future pandemics
“In 20 years, we’ve had three coronavirus epidemics or pandemics –SARS, MERS and COVID-19—so it’s likely that we’ll see another,” said Dr. Auer.
“We think harnessing innate immunity could be one of our best weapons for fighting COVID-19 and could be easily adapted to tackle future pandemics.” – Dr. Rebecca Auer
Donate today to support promising research and clinical trials like this one.
Cancer patients undergoing active treatment who are interested in participating in this trial should speak with their cancer specialist.
The Ottawa Hospital Foundation provided seed funding for this project through the COVID-19 Emergency Response Fund, funded by generous donors in the community. Read about other projects that have received funding thanks to donor support and are making a difference in the fight against COVID-19.
Additional funding and in-kind support for this trial have been provided by the Canadian Cancer Society, BioCanRx, the Ontario Institute for Cancer Research, The Ottawa Hospital Academic Medical Organization, ATGen NK Max Canada, and Immodulon Therapeutics, the manufacturer of IMM-101.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories: Clinical Trials, Clinical Trials, COVID-19, World-Leading Research, World-Leading Research
Exceptional care makes young mother want to give back
When Gina Mertikas-Lavictoire received the good news that she had gone from breast cancer patient to cancer survivor, she knew she wasn’t done with The Ottawa Hospital.
Eternally grateful for the care she received, Gina knew she wanted to give back — she felt that she needed to.
“After my treatment was done, I asked my oncologist, Dr. Mark Clemons — who’s one of the best doctors in the world — ‘how can I give back?’ I need to do something to give back.” – Gina Mertikas-Lavictoire
Gina was 34 years old with three young children at home, the youngest just 12 months old, when she felt something was wrong — there was an unusual firmness in one of her breasts. A breast cancer diagnosis followed and rocked her family’s world. She immediately went into survival mode. “The first thing I asked my doctor was when can I have a mastectomy and when can I start my treatment. I never looked back,” Gina says.
Despite the alarming health news, she faced the disease with sheer determination. “I received excellent care at The Breast Health Centre at The Ottawa Hospital. I went through chemotherapy and radiation. I’ve had four surgeries including a hysterectomy and a double mastectomy.”
An unimaginable experience for a young mother, but the gratitude Gina has for The Ottawa Hospital is undeniable in her desire to give back.
Paying it forward
Gina and her mother, Katerina Mertikas, a renowned local artist
“When I received the news that I would be able to watch my children grow up, that’s when I put the wheels in motion to help others,” recalls Gina. She came up with the idea of selling a calendar to support cancer research at The Ottawa Hospital.
Today, she’s feeling great and is solely focused on her fundraising efforts, which have exceeded her wildest expectations.
“From the get go, the calendars kept selling out. They were just flying off the shelves. What I’m surprised by is the amount of support that I had, not only friends and family but from all of Ottawa and across the country. People are supportive. We’ve even shipped calendars into the United States,” says Gina.
Gina hasn’t done any of this alone. Right alongside her during her diagnosis, treatment, and now the furious fundraising efforts is her family, including her mother Katerina Mertikas. Katerina is a local artist, who is renowned across the country for her beautiful paintings. It’s Katerina’s art, which is featured each month in the calendar.
For Katerina, it was extraordinarily difficult to watch her daughter go through the treatment and surgeries. “There are no words,” says Katerina.
However, the mother of two knows cancer research played a role in helping her youngest daughter recover. “My own daughter has benefitted from research through the treatment she received, which was Herceptin — a chemotherapy drug. It was originally used in a clinical trial before becoming a standard of care for patients,” acknowledges Katerina. It’s for that reason this mother-daughter duo is working together to help others facing the disease.
With calendars from 2019 and 2020 under her belt, and $25,000 raised for cancer research, Gina wants to see this continue for years to come with the help of her own children. Her eldest daughter, Katerina, has been introduced to philanthropy and what it means to give back. For Gina, she’d love to one day hand off the calendar project to the next generation. “I’m hoping someday my kids will take over this calendar and it will continue on,” says the proud mother.
Excellence in care
For this family, there is undeniable gratitude toward the care team at The Ottawa Hospital, which helped Gina when her life depended on it. The impact has been profound on the family and for Katerina, especially from one doctor in particular — Dr. Mark Clemons, medical oncologist and associate scientist at The Ottawa Hospital Cancer Centre.
Dr. Clemons first joined The Ottawa Hospital in 2009 and has made a remarkable name for himself since, both among patients and colleagues alike. At the time, he was unsatisfied with the way breast cancer was being monitored and treated in Canada, so this quickly became his primary area of specialty for clinical trials.
In fact, in 2014, along with Dr. Dean Fergusson, Director of the Clinical Epidemiology Program, Dr. Clemons developed the Rethinking Clinical Trials or REaCT program as a way to make the process of enrolling in clinical trials easier and more efficient for cancer patients. As of June 2020, this groundbreaking program had enrolled over 2,600 patients, making it the largest pragmatic cancer trials program in Canada. In recognition of their success, the REaCT team recently earned a 2020 Research Excellence Team Award from The Ottawa Hospital. Dr. Clemons was also the recipient of the Chrétien Researcher of the Year Award in 2013.
For Gina, she is grateful to have been cared for by such an accomplished researcher who also happens to be a compassionate physician. Dr. Clemons offered guidance, encouragement and hope when she needed it most, and this inspired her to give back.
“Dr. Mark Clemons is a very special doctor,” says Katerina. “He made us feel so comfortable. He helped a lot with his attitude. He gave it his all — so how could we not give back? I wish we could give more.” – Gina Mertikas-Lavictoire
Listen to Pulse Podcast, and hear Gina’s story, including a special guest appearance by Dr. Mark Clemons.
The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.
Categories:
Now available, in limited quantities, these stunning t-shirts are raising funds for The Craig Kulig Memorial Fund and cancer research at Ottawa Hospital.
We are hoping to send out a small ripple of Wearable Happiness – One t-shirt at a time with all proceeds going to The Craig Kulig Memorial Fund.
Bright and spotted with champagne bubbles that effervesce from the earth, Darlene Kulig’s artworks are utterly joyful. Kulig refers to her style as semi- abstracted spirited landscape. Her stylized art builds on her experience as a graphic designer, and in each new painting she explores light, rhythm, color, and the life force of her subjects. The 12 images in this calendar reflect her home in Canada and her travels abroad.
Darlene’s signature style is described as semi-abstracted spirited landscape and her love of the beauty available in the Canadian landscape is clear. What is especially impressive is that she has developed a unique very personal approach that “feels” Canadian and is utterly joyful.
Darlene’s award winning work has been featured in North American publications and Global Affairs Canada has installed a selection of Kulig Canadian Landscapes in Canadian Embassies buildings around the world. The Mayo clinic has Darlene’s work hanging in the Rochester Clinic and Pomegranate Communications has licensed Darlene’s work in their international product line.
A member of the Etobicoke Art Group and Neilson Park Creative Centre where she studies and paints, you can find her work in galleries across Canada and the United States as well as private collections around the world.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.